Zealand Pharma (ZEAL): next trial readout expected around 2027-04-12
Trials that could report in the next 12 months: 4BiopharmaCTG
Catalyst timeline
Dates are estimated from each trial's registered completion date — none are FDA decision dates. Counts trials that fit our shared poll budget, not everything ZEAL is running — see methodology.
- 2027-04-12in 34wPharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function
- 2027-09-06in 55wA Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity
- 2028-09-18in 109wEfficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
- 2028-10-23in 114wEfficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Pipeline
| Program | Phase | Status | Primary completion | Trial |
|---|---|---|---|---|
| Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS | Phase 3 | Recruitingstill enrolling patients | 2028-10-23 | NCT07197944 |
| Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short B… | Phase 3 | Active Not Recruitingenrolled, still running | 2028-09-18 | NCT07228403 |
| A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerabil… | Early Phase 1 | Recruitingstill enrolling patients | 2027-09-06 | NCT07721597 |
| Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic… | Phase 1 | Recruitingstill enrolling patients | 2027-04-12 | NCT07682818 |
| A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it… | Phase 1 | Recruitingstill enrolling patients | NCT07733089 |
Status-change history
Every ClinicalTrials.gov change recorded for ZEAL's trials — a running history no other tracker shows.
No status changes detected yet for this ticker.
Frequently asked
When is ZEAL's next PDUFA date?
No disclosed PDUFA date is currently tracked for this ticker.
What phase is ZEAL's lead program in?
Phase 3 — active not recruiting.
Where does this data come from?
ClinicalTrials.gov v2 API (trial status + diffs) and company 8-K/press-release disclosures (PDUFA dates). Every number links to its source.